Missing/wrong data?
Log in to edit
RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial
scientific article published on 9 November 2018
Author/s
author: Graham P Collins, Louise Stanton, Peter Johnson, Joke Dhondt, Andrew Davies
Work details
Publication date
November 9, 2018
-
-
Language
English
Copyright status
copyrighted